Pricing Log in Create free account

Onconetix, Inc. (ONCO) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

Onconetix, Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. Onconetix, Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($3.2M and $3.2M). 60 Degrees Pharmaceuticals Inc. grew revenue faster over the last twelve months: 23.4% against −51.3%. 60 Degrees Pharmaceuticals Inc. has the higher net margin (−678.0% vs −1,578.6%) and the lower return on invested capital (−348.6% vs −135.4%). Across the 15 metrics below, 60 Degrees Pharmaceuticals Inc. leads on 9 and Onconetix, Inc. on 6.

Valuation

Metric ONCO SXTP Biotechnology median
P/E n/m n/m 10.60
P/S 23.65 1.31 9.40
P/B 1.13 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 14.63 1.47 9.02
Earnings yield (2,931.13%) (1,046.67%) (32.88%)
Free cash flow yield (67.68%) (569.15%) (23.13%)

Profitability

Metric ONCO SXTP Biotechnology median
Gross margin 80.38% 43.42% 68.51%
Operating margin (2,524.73%) (691.33%) 0.00%
Net margin (1,578.60%) (678.03%) 0.00%
Free cash flow margin (1,595.90%) (745.93%) 0.00%
Return on equity (105.23%) 115.54% (51.96%)
Return on assets (57.37%) (194.65%) (46.06%)
Return on invested capital (135.42%) (348.64%) 0.00%

Growth

Metric ONCO SXTP Biotechnology median
Revenue growth (TTM) (51.33%) 23.41% 6.76%
EPS growth (last fiscal year) 99.09% 84.19% 29.88%
Revenue growth, 5-year CAGR — (11.18%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ONCO SXTP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.21 2.32 4.97
Net debt to EBITDA 0.29 0.37 1.01

Dividend

Metric ONCO SXTP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ONCO SXTP Biotechnology median
Market cap 3.24m 3.22m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack